The Claim
Genetic deletion of p16 in a mouse model with a nuclear localization sequence mutation and C-terminal deletion in PTHrP extends lifespan from 1–3 weeks to 2–4 weeks, increases body weight and skeletal growth, and increases bone volume by reducing cellular senescence in bone marrow mesenchymal stem cells and osteoblasts.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In genetically modified mice with a specific PTHrP mutation, removing the p16 gene results in longer lifespan, greater body weight, improved skeletal growth, and higher bone volume due to reduced cellular senescence in bone marrow stem cells and bone-forming cells.
See the scientific wording
Genetic deletion of p16 in a mouse model with PTHrP nuclear localization sequence and C-terminal deletion extends lifespan from 1–3 weeks to 2–4 weeks, improves body weight and skeletal growth, and increases bone volume by reducing cellular senescence in bone marrow mesenchymal stem cells and osteoblasts.
When a key bone-growth signal is broken, cells in the bone marrow become damaged and stop dividing, which stops bone growth and weakens bones. Removing a gene called p16 lets these damaged cells start dividing again, clears out the non-working cells, and allows new bone to form normally, which helps the body grow bigger and live longer.
What the research says
1 studyIn mice that are born with a broken bone-growing gene and die young, scientists removed another gene called p16. This made the mice live longer, grow bigger, and develop stronger bones because fewer damaged, non-working cells built up in their bone tissue.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.